Ranbaxy, its partners and Actavis have signed a non-exclusive agreement.
Markets across the globe are rallying on hopes that the US Federal Reserve won't lift interest rates until 2016.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances